Literature DB >> 20029894

An accelerated failure time mixture cure model with masked event.

Jenny J Zhang1, Molin Wang.   

Abstract

We extend the Dahlberg and Wang (Biometrics 2007, 63, 1237-1244) proportional hazards (PH) cure model for the analysis of time-to-event data that is subject to a cure rate with masked event to a setting where the PH assumption does not hold. Assuming an accelerated failure time (AFT) model with unspecified error distribution for the time to the event of interest, we propose rank-based estimating equations for the model parameters and use a generalization of the EM algorithm for parameter estimation. Applying our proposed AFT model to the same motivating breast cancer dataset as Dahlberg and Wang (Biometrics 2007, 63, 1237-1244), our results are more intuitive for the treatment arm in which the PH assumption may be violated. We also conduct a simulation study to evaluate the performance of the proposed method.

Entities:  

Mesh:

Year:  2009        PMID: 20029894      PMCID: PMC4669581          DOI: 10.1002/bimj.200800244

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  13 in total

1.  A nonparametric mixture model for cure rate estimation.

Authors:  Y Peng; K B Dear
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Estimation in a Cox proportional hazards cure model.

Authors:  J P Sy; J M Taylor
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

3.  A semi-parametric accelerated failure time cure model.

Authors:  Chin-Shang Li; Jeremy M G Taylor
Journal:  Stat Med       Date:  2002-11-15       Impact factor: 2.373

4.  Cure fraction estimation from the mixture cure models for grouped survival data.

Authors:  Binbing Yu; Ram C Tiwari; Kathleen A Cronin; Eric J Feuer
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

5.  A new estimation method for the semiparametric accelerated failure time mixture cure model.

Authors:  Jiajia Zhang; Yingwei Peng
Journal:  Stat Med       Date:  2007-07-20       Impact factor: 2.373

6.  A proportional hazards cure model for the analysis of time to event with frequently unidentifiable causes.

Authors:  Suzanne E Dahlberg; Molin Wang
Journal:  Biometrics       Date:  2007-12       Impact factor: 2.571

7.  Modelling menstrual status during and after adjuvant treatment for breast cancer.

Authors:  Suzanne E Szwarc; Marco Bonetti
Journal:  Stat Med       Date:  2006-10-30       Impact factor: 2.373

8.  Semi-parametric estimation in failure time mixture models.

Authors:  J M Taylor
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

9.  Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.

Authors:  Monica Castiglione-Gertsch; Anne O'Neill; Karen N Price; Aron Goldhirsch; Alan S Coates; Marco Colleoni; M Laura Nasi; Marco Bonetti; Richard D Gelber
Journal:  J Natl Cancer Inst       Date:  2003-12-17       Impact factor: 13.506

10.  Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.

Authors:  H de Haes; M Olschewski; M Kaufmann; M Schumacher; W Jonat; W Sauerbrei
Journal:  J Clin Oncol       Date:  2003-11-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.